The Goldilocks Price: Structuring Branded Generic Pricing to Beat Both Innovators and Pure Generics
Drug pricing is stuck in a Goldilocks traptoo high for generics, too low for innovators. Heres the policy fix that could finally make the market work.
If youve ever watched a pricing model fail in real time, you know the pattern: the rules are written …
